INTRODUCTION
Vav is a proto-oncogene product that is exclusively expressed in haematopoietic cells. It possesses multiple motifs homologous to a variety of proteins that are involved in transcriptional regulation and signal transduction events. These motifs include a helix-loop-helix domain at the N-terminus, a leucine zipper, two zinc fingers, an acidic domain, two nuclear localization domains, as well as an SH2 and two SH3 domains [1] . Proto-a also encodes a domain which shares sequence similarity with mcf.2 (dbl)bcr and CDC24 [2] . The corresponding domain of dbl has recently been shown to function as a guanine nucleotide exchange factor for a Ras-related protein, CDC42H [3] .
Vav is associated, through its SH2 domain, with either src or Janus family kinases (JAK) [4, 5] . Activation of these kinases in T-or B-lymphocytes via the T-cell antigen receptor (TCR) or Bcell antigen receptor (BCR) mediates the tyrosine phosphorylation of Vav [4, 6, 7] . In addition, Vav becomes tyrosine phosphorylated in monocytes stimulated via the Fcγ receptor I (FcγRI) or receptor II (FcγRII) [8] and in myeloid cells stimulated via the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 3 (IL-3) or c-kit receptors [5] .
The significance of Vav tyrosine phosphorylation has not been finally established. It was suggested that tyrosine-phosphorylated Vav was responsible for guanine nucleotide exchange activity and may therefore activate the Ras protein [4, 6, 9, 10] . These results, however, have not been successfully reproduced in other laboratories [5, 11] . More recent studies have demonstrated that the SH3 domain of Vav is associated with poly(rC)-specific RNA-binding proteins [12, 13] , suggesting a role for Vav in the regulation of the late steps of RNA biogenesis by modulating the function of poly(rC)-specific RNA ribonucleoproteins. Recent studies involving mutational analyses and knock-out of the Vav gene in transgenic mice revealed that antigen receptor signalling and positive selection of immature CD4 + CD8 + into CD4 + CD8 − Abbreviations used : NK, natural killer ; LAK-NK, interleukin 2-activated NK cells ; PLC, phospholipase C ; FcγRI, Fcγ receptor I ; IL-3, interleukin 3 ; PBMC, peripheral blood mononuclear cells ; ECL, enhanced chemiluminescence ; PAA, phosphoamino acids ; PVDF, poly(vinylidene difluoride) ; mAb, monoclonal antibody.
* To whom correspondence should be addressed. or CD4 − CD8 + thymocytes are severely impaired in Vav-deficient T lymphocytes [14] [15] [16] . These studies therefore provide unambiguous evidence that Vav is obligatory for antigen receptormediated T-cell signalling, though the exact role of Vav tyrosine phosphorylation in this signalling remains to be elucidated. Natural killer (NK) cells express low-affinity FcγIIIA receptors which function to mediate antibody-dependent cell cytotoxicity and cytokine production. FcγIIIA receptor is composed of a multimeric complex, including the CD16 molecule in association with ζ-γ, ζ-ζ and\or γ-γ disulphide-linked dimers [17] . Activation of NK cells through cross-linking of CD16 elicits a cascade of signalling events, including activation of p56 lck [18] [19] [20] [21] and p72 syk \Zap70 kinases [22, 23] , tyrosine phosphorylation and activation of phospholipase C (PLC) [20, 24] , leading to the breakdown of phosphatidylinositol into inositol-1,4,5-triphosphate and calcium mobilization [25] . Recent studies demonstrated that a lipid kinase, phosphatidylinositol 3-kinase (PI-3), is activated upon CD16 cross-linking and is involved in granule exocytosis and antibody-dependent cellular cytotoxicity [26, 27] . In the present study, we provide evidence that upon CD16 cross-linking, Vav became tyrosine phosphorylated and was associated with a tyrosine-phosphorylated 70 kDa protein.
In itro kinase assays with Vav immunoprecipitates revealed that Vav was associated with a constitutively active serine\threonine kinase. These results suggest that Vav, via tyrosine, serine and threonine phosphorylation events, may play a role in regulating cytokine production, natural killing and\or antibody-dependent cellular cytotoxicity in NK cells. . A doublet of unidentified proteins around 55 kDa which was not reproducibly present in the immunoprecipitates is indicated by an asterisk. To confirm that equal amounts of Vav were immunoprecipitated in each sample, membrane was stripped in a buffer containing 100 mM 2-mercaptoethanol, 2 % SDS, and 6.25 mM Tris/HCl, pH 6.7, at 50 mC for 30 min, and reprobed with anti-Vav mAb and ECL (C). Abbreviation : GαM, goat anti-(mouse IgG).
MATERIALS AND METHODS

Cells
(v\v) fetal bovine serum (FBS), 15 % (v\v) Lymphocult-T (Biotest, NJ, U.S.A.) and 10 Cetus units\ml IL-2 (Chiron, Emeryville, CA, U.S.A.). Cells were maintained at (2.5-10)i10& cells\ml and passaged into fresh media every 3-4 days. Peripheral blood mononuclear cells (PBMCs) were isolated from healthy donors by Ficoll-Hypaque separation (Pharmacia, Piscataway, NJ, U.S.A.) as described previously [28] . IL-2-activated NK cells (LAK-NK) were prepared as previously described [28] . Briefly, PBMCs were depleted of adherent cells by passage through a nylon column, and then the cells were cultured in RPMI 1640 medium supplemented with 10 % (v\v) pooled human serum in the presence of IL-2 (1000 Cetus units\ml) for 24 h. The nonadherent cells were removed and the adherent cells were maintained in autologous conditioned-medium with IL-2 and gammairradiated phytohaemagglutinin-stimulated PBMCs. Activated cells obtained by this procedure were 90 % CD3 − CD16 + NK cells.
Reagents
Anti-CD16 monoclonal antibody (mAb), 3G8, was purchased from Immunotech (San Westbrook, ME, U.S.A.). Antiphosphotyrosine mAb, 4G10, anti-Vav mAb and anti-Vav rabbit serum, anti-p56 lck and anti-p59 fyn antibodies were purchased from UBI (Lake Placid, NY, U.S.A.). Herbimycin A was purchased from Gibco (Grand Island, NY, U.S.A.).
Stimulation of NK cells, immunoprecipitation and Western blotting
Cells (5i10') were washed twice with Hanks buffered salt solution and then resuspended in 1 ml of warm serum-free RPMI 1640 medium. Cells were then stimulated with 2 µg of anti-CD16 mAb (3G8) at 37 mC for 10 min, then cross-linked with 8 µg of goat anti-(mouse IgG) for various lengths of time. Cells were rapidly centrifuged and lysed in Brij 96 buffer (20 mM Tris\HCl, pH 8.0, 150 mM NaCl, 1 mM PMSF, 1 % Brij 96). Post-nuclear cell lysates were precleared with Pansorbin, and immunoprecipitation with various antibodies was performed. Immunoprecipitates or cell lysates were resolved in SDS\8 %-polyacrylamide gels and transferred to nitrocellulose membranes. Proteins of interest were detected with various specific antibodies followed by enhanced chemiluminescence (ECL ; Amersham, IL, U.S.A.). To confirm that equal amounts of proteins were immunoprecipitated, the nitrocellulose membrane was stripped in the buffer (100 mM 2-mercaptoethanol, 2 % SDS and 6.25 mM Tris\HCl, pH 6.7) at 50 mC for 30 min and then reprobed with the same antibody that was used for immunoprecipitation.
In vitro kinase assay
NK3.3 cells were stimulated with anti-CD16 mAb as described above. Cell lysates were prepared in Brij 96 buffer, and Vav was immunoprecipitated with an anti-Vav polyclonal antibody (UBI). Immune-complexes were extensively washed in Brij 96 buffer, then 50 µl of kinase buffer (50 mM Hepes\HCl, pH 7.5, 10 mM MgCl # , 10 µCi [γ-$#P]ATP) was added to each sample and then incubated at 30 mC for 15 min. The kinase reaction was terminated by the addition of 50 µl of 2i sample buffer. The reaction mixture was separated on a 10 % polyacrylamide gel, the gel was then dried and exposed to X-Omat film.
Phosphoamino acid (PAA) analyses
The in itro kinase reaction as described above was resolved on a 10% gel and then transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, MA, U.S.A.). The membrane was washed with distilled water, air-dried, and then exposed to X-Omat film. The band of interest was sliced from the membrane, and the $#P-labelled protein was directly hydrolysed in 6 M HCl at 110 mC for 1 h. The supernatant was transferred to another Eppendorf tube and lyophilized by speed-vacuum (Speed-Vac AS160, Savant, NY, U.S.A.). The PAAs were reconstituted in 10 µl of PAA sample buffer [15 vol . pH 1.9 firstdimension buffer and 1 vol. cold PAA (1 mg\ml each phosphoserine, phosphothreonine and phosphotyrosine) (Sigma, St. Louis, MO, U.S.A.)]. An aliquot (5 µl) of each sample was loaded on to a cellulose TLC plate. PAAs were separated in a Hunter 7000 unit (C.B.S. Scientific, Del Mar, CA, U.S.A.) in pH 1.9 buffer at 1.6 kV for 20 min in the first dimension and then in pH 3.5 buffer at 1.2 kV for 16 min in the second dimension. PAAs were visualized by spraying with 0.25 % ninhydrin in acetone. The $#P-labelled PAAs were visualized by exposure to X-Omat film.
Quantification of protein tyrosine phosphorylation
The exposed X-Omat films from the in itro tyrosine kinase assays or the phosphorylated proteins detected on Western blots were scanned in an LKB densitometer (2202 Ultrascan laser densitometer). The peaks corresponding to the bands of interest were integrated to determine the relative amounts of phosphorylation.
RESULTS
Tyrosine phosphorylation of Vav in NK cells upon stimulation of CD16
Cross-linking of CD16 in NK3. Induction of Vav tyrosine phosphorylation following CD16 stimulation was also confirmed using LAK-NK cells. As shown in Figure 2 
Specific interaction of Vav with Vav-associated proteins
The specificity of Vav interaction with a 70 kDa protein in LAK-NK cells was confirmed by immunoprecipitating Vav in the presence of the ionic detergent, SDS. As shown in Figure 3 Figure 1 (A) , cell lysates were prepared and Vav-associated kinase assay was performed as described in (A).
SDS resulted in the disappearance of that 70 kDa protein, whereas approximately equal amounts of Vav were immunoprecipitated (Figure 3) . Therefore, the ionic detergent SDS in the lysis buffer resulted in the disappearance of the 70 kDa protein, suggesting that this protein is immunoprecipitated not due to cross-reactivity with the anti-Vav polyclonal antibody, but rather due to its association with Vav.
Inhibition of Vav tyrosine phosphorylation by herbimycin A
To examine the specificity of Vav tyrosine phosphorylation, NK3.3 cells were treated for 16 h with various concentrations of the tyrosine kinase inhibitor, herbimycin A. NK3.3 cells were then stimulated with anti-CD16 mAb and cross-linking goat anti-(mouse IgG), then cell lysates were prepared, Vav was immunoprecipitated and examined for tyrosine phosphorylation. As shown in Figure 4 
Vav is associated with a constitutively active serine/threonine kinase
Since it has been previously reported that Vav is tyrosine phosphorylated and activated in Jurkat T-cell lysate by recombinant p56 lck kinase in an in itro kinase assay [4] , and in addition, that Vav is associated with JAK kinase in a human myeloid cell line, MO7e [5] , we tested whether anti-Vav immunoprecipitates from NK cells contained tyrosine kinase activity. One major 58 kDa protein was phosphorylated in itro with antiVav immunoprecipitates from unstimulated ( Figure 5A, lane 2) or stimulated ( Figure 5A, lane 3) NK3.3 cells ; although this 58 kDa band is about the size of p56 lck or p59 fyn , this phosphorylated protein migrated somewhat slower than p56 lck but slightly faster than p59 fyn ( Figure 5A ). In addition, this phosphorylated 58 kDa protein could not be reimmunoprecipitated with either anti-p56 lck or anti-p59 fyn antibody (results not shown), excluding the possibility that this p58 protein is p56 lck or p59 fyn . PAA analyses of the 58 kDa protein showed that this protein was phosphorylated only on serine and threonine residues but not on tyrosine residues ( Figure 5A ). These experiments therefore indicated that Vav in NK3.3 cells is associated with a serine\threonine kinase rather than with the tyrosine kinases p56 lck or p59 fyn . Similar results were obtained with LAK-NK cells (results not shown).
The specific association of the 58 kDa protein with Vav was also confirmed by immunoprecipitating with either anti-Vav mAb or anti-Vav polyclonal antibody under various stringent conditions, and then subjecting the immunoprecipitates to an in itro kinase assay. As shown in Figure 5C ). These results collectively suggest that Vav is specifically associated with the 58 kDa protein.
Finally, we tested whether the Vav-associated serine\threonine kinase is activated by stimulation of CD16. As shown in Figure  5 (D), cross-linking of CD16 did not increase phosphorylation of the 58 kDa protein, suggesting that an active serine\threonine kinase is constitutively associated with Vav. [17] . It has been previously reported that cross-linking of FcγRI and FcγRII on monocytes activates only p72 syk kinase, which in turn phosphorylates tyrosine residues of several intracellular proteins, including phospholipase C (PLC)-γ1, PLC-γ2, Vav and GAP [8] . Cross-linking of FcγRIIIA on NK cells activates both p72 syk and p56 lck which probably phosphorylate PLC-γ1, PLC-γ2 and the ζ chain [24, 29] . In the present study, we report that cross-linking of FcγRIIIA also induces Vav tyrosine phosphorylation.
DISCUSSION
Previous studies have demonstrated that Vav associates with two proteins in haematopoietic cells. One protein, which constitutively associates with Vav via the SH2 domain is a 62 kDa poly(rC)-specific RNA-binding protein observed in Jurkat cells [5] . This 62 kDa protein was not observed in our experiments with NK3.3 and LAK-NK cells detected by anti-phosphotyrosine. Because of the lack of a specific antibody for this 62 kDa protein, we cannot confirm that it is not associated with Vav. The second associated protein, which binds via the SH2 domain of Vav, is a 70 kDa protein, designated as Vap-1, observed in B lymphocytes [7] . We demonstrate in this study that in LAK-NK cells, a 70 kDa protein associated with Vav became tyrosine phosphorylated upon stimulation of FcγRIII. Since the antibody against Vap-1 is not available, we currently are unable to determine whether this 70 kDa protein in LAK-NK cells is identical to Vap-1. Interestingly, tyrosine phosphorylation and association of this 70 kDa protein with Vav was not observed in NK3.3 cells.
We also report the association of an unidentified serine\ threonine kinase with Vav. In itro kinase assay revealed that this serine\threonine kinase phosphorylates a single 58 kDa protein in Vav immunoprecipitates. In addition, this serine\threonine kinase is constitutively associated with Vav and is in an active state ; cross-linking of CD16 did not enhance the activity of serine\threonine kinase associated with Vav. We speculate that this unidentified serine\threonine kinase may play an important role in regulating signals through co-translocation with Vav or by phosphorylating Vav-associated proteins, such as the 58 kDa protein. In contrast to previous reports that Vav is activated by and associates with tyrosine kinases [4, 5] , we did not detect any tyrosine kinase activity in Vav immunoprecipitates from NK3.3 nor LAK-NK cells.
The events downstream of activated Vav have not been completely defined ; however, it is clear that Vav is an important participant in T-cell signalling. Our current studies with NK cells reveal that Vav was tyrosine phosphorylated in NK cells following stimulation of CD16, suggesting that Vav also plays a role in CD16-triggering of the signalling pathway of NK cells. In addition, Vav was associated with an unidentified 70 kDa protein in LAK-NK cells. Finally, we report here that Vav was additionally associated with a constitutively active serine\threonine kinase. Molecular cloning and identification of this serine\ threonine kinase, as well as the Vav-associated proteins, will lead to a better understanding of how Vav functions to regulate the expression of CD16-mediated cytotoxicity and cytokine production in NK cells.
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